vs

Side-by-side financial comparison of ICHOR HOLDINGS, LTD. (ICHR) and INNOSPEC INC. (IOSP). Click either name above to swap in a different company.

INNOSPEC INC. is the larger business by last-quarter revenue ($453.2M vs $256.1M, roughly 1.8× ICHOR HOLDINGS, LTD.). INNOSPEC INC. runs the higher net margin — 6.8% vs -1.0%, a 7.8% gap on every dollar of revenue. On growth, ICHOR HOLDINGS, LTD. posted the faster year-over-year revenue change (4.7% vs 2.8%). Over the past eight quarters, ICHOR HOLDINGS, LTD.'s revenue compounded faster (12.3% CAGR vs 2.1%).

Ichor Holdings Ltd. designs, manufactures and supplies critical fluid delivery systems, subsystems and related components for the global semiconductor manufacturing sector. Its products are integrated into front-end wafer processing equipment, supporting production of advanced logic, memory and specialty chips for leading semiconductor device and equipment makers across North America, East Asia and Europe.

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives. The Oilfield Services business supplies drilling, completion and production chemicals.

ICHR vs IOSP — Head-to-Head

Bigger by revenue
IOSP
IOSP
1.8× larger
IOSP
$453.2M
$256.1M
ICHR
Growing faster (revenue YoY)
ICHR
ICHR
+1.9% gap
ICHR
4.7%
2.8%
IOSP
Higher net margin
IOSP
IOSP
7.8% more per $
IOSP
6.8%
-1.0%
ICHR
Faster 2-yr revenue CAGR
ICHR
ICHR
Annualised
ICHR
12.3%
2.1%
IOSP

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ICHR
ICHR
IOSP
IOSP
Revenue
$256.1M
$453.2M
Net Profit
$-2.5M
$30.8M
Gross Margin
12.6%
27.3%
Operating Margin
88.2%
8.1%
Net Margin
-1.0%
6.8%
Revenue YoY
4.7%
2.8%
Net Profit YoY
45.8%
-8.3%
EPS (diluted)
$-0.07
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICHR
ICHR
IOSP
IOSP
Q1 26
$256.1M
$453.2M
Q4 25
$223.6M
$455.6M
Q3 25
$239.3M
$441.9M
Q2 25
$240.3M
$439.7M
Q1 25
$244.5M
$440.8M
Q4 24
$233.3M
$466.8M
Q3 24
$211.1M
$443.4M
Q2 24
$203.2M
$435.0M
Net Profit
ICHR
ICHR
IOSP
IOSP
Q1 26
$-2.5M
$30.8M
Q4 25
$-16.0M
$47.4M
Q3 25
$-22.9M
$12.9M
Q2 25
$-9.4M
$23.5M
Q1 25
$-4.6M
$32.8M
Q4 24
$-3.9M
$-70.4M
Q3 24
$-2.8M
$33.4M
Q2 24
$-5.1M
$31.2M
Gross Margin
ICHR
ICHR
IOSP
IOSP
Q1 26
12.6%
27.3%
Q4 25
9.4%
28.0%
Q3 25
4.6%
26.4%
Q2 25
11.3%
28.0%
Q1 25
11.7%
28.4%
Q4 24
11.6%
29.2%
Q3 24
13.2%
28.0%
Q2 24
12.6%
29.2%
Operating Margin
ICHR
ICHR
IOSP
IOSP
Q1 26
88.2%
8.1%
Q4 25
-6.2%
10.3%
Q3 25
-8.1%
1.3%
Q2 25
-2.0%
7.8%
Q1 25
-0.5%
9.6%
Q4 24
-0.5%
8.8%
Q3 24
-0.2%
10.3%
Q2 24
-1.1%
9.4%
Net Margin
ICHR
ICHR
IOSP
IOSP
Q1 26
-1.0%
6.8%
Q4 25
-7.1%
10.4%
Q3 25
-9.6%
2.9%
Q2 25
-3.9%
5.3%
Q1 25
-1.9%
7.4%
Q4 24
-1.7%
-15.1%
Q3 24
-1.3%
7.5%
Q2 24
-2.5%
7.2%
EPS (diluted)
ICHR
ICHR
IOSP
IOSP
Q1 26
$-0.07
$1.22
Q4 25
$-0.46
$1.90
Q3 25
$-0.67
$0.52
Q2 25
$-0.28
$0.94
Q1 25
$-0.13
$1.31
Q4 24
$-0.11
$-2.80
Q3 24
$-0.08
$1.33
Q2 24
$-0.15
$1.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICHR
ICHR
IOSP
IOSP
Cash + ST InvestmentsLiquidity on hand
$89.1M
$289.1M
Total DebtLower is stronger
$6.3M
Stockholders' EquityBook value
$668.0M
$1.4B
Total Assets
$972.5M
$1.8B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICHR
ICHR
IOSP
IOSP
Q1 26
$89.1M
$289.1M
Q4 25
$98.3M
$292.5M
Q3 25
$92.5M
$270.8M
Q2 25
$92.2M
$266.6M
Q1 25
$109.3M
$299.8M
Q4 24
$108.7M
$289.2M
Q3 24
$116.4M
$303.8M
Q2 24
$114.3M
$240.2M
Total Debt
ICHR
ICHR
IOSP
IOSP
Q1 26
$6.3M
Q4 25
$123.5M
Q3 25
$123.5M
Q2 25
$125.0M
Q1 25
$126.8M
Q4 24
$128.5M
Q3 24
$130.3M
Q2 24
$130.2M
Stockholders' Equity
ICHR
ICHR
IOSP
IOSP
Q1 26
$668.0M
$1.4B
Q4 25
$663.9M
$1.3B
Q3 25
$676.2M
$1.3B
Q2 25
$694.1M
$1.3B
Q1 25
$700.4M
$1.3B
Q4 24
$698.3M
$1.2B
Q3 24
$697.3M
$1.2B
Q2 24
$694.9M
$1.2B
Total Assets
ICHR
ICHR
IOSP
IOSP
Q1 26
$972.5M
$1.8B
Q4 25
$942.9M
$1.8B
Q3 25
$966.6M
$1.8B
Q2 25
$985.1M
$1.8B
Q1 25
$1.0B
$1.8B
Q4 24
$995.6M
$1.7B
Q3 24
$975.9M
$1.8B
Q2 24
$947.7M
$1.7B
Debt / Equity
ICHR
ICHR
IOSP
IOSP
Q1 26
0.01×
Q4 25
0.19×
Q3 25
0.18×
Q2 25
0.18×
Q1 25
0.18×
Q4 24
0.18×
Q3 24
0.19×
Q2 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICHR
ICHR
IOSP
IOSP
Operating Cash FlowLast quarter
$17.6M
Free Cash FlowOCF − Capex
$-10.0M
FCF MarginFCF / Revenue
-3.9%
Capex IntensityCapex / Revenue
2.8%
2.0%
Cash ConversionOCF / Net Profit
0.57×
TTM Free Cash FlowTrailing 4 quarters
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICHR
ICHR
IOSP
IOSP
Q1 26
$17.6M
Q4 25
$9.2M
$61.4M
Q3 25
$9.2M
$39.3M
Q2 25
$-7.5M
$9.3M
Q1 25
$19.0M
$28.3M
Q4 24
$-2.5M
$25.7M
Q3 24
$8.1M
$73.5M
Q2 24
$17.5M
$4.7M
Free Cash Flow
ICHR
ICHR
IOSP
IOSP
Q1 26
$-10.0M
Q4 25
$5.9M
$46.8M
Q3 25
$2.1M
$25.0M
Q2 25
$-14.8M
$-3.7M
Q1 25
$496.0K
$19.9M
Q4 24
$-6.9M
$13.6M
Q3 24
$2.2M
$65.8M
Q2 24
$14.6M
$-6.2M
FCF Margin
ICHR
ICHR
IOSP
IOSP
Q1 26
-3.9%
Q4 25
2.6%
10.3%
Q3 25
0.9%
5.7%
Q2 25
-6.2%
-0.8%
Q1 25
0.2%
4.5%
Q4 24
-3.0%
2.9%
Q3 24
1.0%
14.8%
Q2 24
7.2%
-1.4%
Capex Intensity
ICHR
ICHR
IOSP
IOSP
Q1 26
2.8%
2.0%
Q4 25
1.5%
3.2%
Q3 25
3.0%
3.2%
Q2 25
3.0%
3.0%
Q1 25
7.6%
1.9%
Q4 24
1.9%
2.6%
Q3 24
2.8%
1.7%
Q2 24
1.4%
2.5%
Cash Conversion
ICHR
ICHR
IOSP
IOSP
Q1 26
0.57×
Q4 25
1.30×
Q3 25
3.05×
Q2 25
0.40×
Q1 25
0.86×
Q4 24
Q3 24
2.20×
Q2 24
0.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons